Journal
EUROPEAN RESPIRATORY JOURNAL
Volume 33, Issue 1, Pages 213-216Publisher
EUROPEAN RESPIRATORY SOC JOURNALS LTD
DOI: 10.1183/09031936.00157707
Keywords
Anagrelide; chronic myeloproliferative disorder; defibrotide; pulmonary hypertension; pulmonary veno-occlusive disease
Categories
Ask authors/readers for more resources
The present study reports a case of biopsy-proven pulmonary veno-occlusive disease as a cause of severe pulmonary hypertension in a patient suffering from a chronic myeloproliferative disorder. The pulmonary disease evolved favourably under treatment with defibrotide, a pro-fibrinolytic medication used in hepatic veno-occlusive disease.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
